cerenovus Archives - Medical Design Sourcing

J&J’s Cerenovus launches next-gen stroke revascularization catheter

The CereGlide 71 catheter. [Image from Johnson & Johnson’s Cerenovus]Johnson & Johnson MedTech’s Cerenovus today announced the launch of its next-generation CereGlide 71 intermediate catheter with TruCourse.

The catheter’s indication covers the revascularization of patients suffering from acute ischemic stroke. It joins the company’s planned CereGlide family of catheters set to enhance the Cerenovus Stroke Solutions portfolio. The company said it optimized the system for effective direct aspiration and for the delivery of compatible stent retrievers. That includes the EmboTrap III revascularization device into the neurovasculature.

Cerenovus equipped the system with TruCourse technology to increase the flexibility of the device. It designed it to help physicians with improved navigation and access to clots, even in challenging anatomical conditions. The company said it provides optimal compatibility, durable delivery and reliable tr…

January 2024 edition: The Leadership in Medtech issue

Opening the brain’s secret back door: A conversation with Synchron co-founder and CEO Dr. Tom Oxley

How Recor Medical won the renal denervation race for FDA approval

Medtech’s biggest personnel moves of 2023

Leadership and innovation in medtech

Creativity, energy, agility — those are three words Recor Medical CEO Lara Barghout used to describe the culture at the world’s first device developer to win FDA approval for hypertension-treating renal denervation (RDN).

You can add persistence to that list. Ever since its founding in 2009, Recor Medical and its team has been pushing to deliver a safe and effective RDN system. The seemingly long odds got longer as larger competitors pulled the plug on their own programs — or in Medtronic’s case, pushed on despite clinical trial failures and won approval shortly after Recor.

Our annual Leadership in Medtech issue of Medical Design &a…

Cerenovus President Mark Dickinson on the future of stroke care

Cerenovus President Mark Dickinson forecasts the innovative technologies that will advance stroke care in the coming years.

Cerenovus Worldwide President Mark Dickinson [Photo courtesy of Johnson & Johnson MedTech]

It’s getting harder to beat aspiration systems for fast and simple thrombectomies to remove blood clots that are blocking oxygen from a stroke patient’s brain.

That’s according to Cerenovus Worldwide President Mark Dickinson, who discussed the future of stroke care in an interview with Medical Design & Outsourcing.

“It’s a very simple concept that the larger the tube you can get to face the blood clot, the more likely you’re going to be able to evacuate that clot just through suction,” he said. “And advances in technology have enabled us — and, candidly, others in the marketplace — to be able to design these larger bore, larger sized devi…

Device design and development tips for the future of stroke care

Michael Gilvarry is the GM of Cerenovus in Galway, Ireland. [Photo courtesy of Johnson & Johnson MedTech]

Simplicity and speed will be the most important innovations for medical devices that treat strokes in the years ahead.

That’s according to Michael Gilvarry, GM of Johnson & Johnson MedTech’s Cerenovus business. While he declined to divulge his neurovascular unit’s plans for future products, he offered advice for other device developers in a field where every minute counts.

A large vessel ischemic stroke can destroy more than 2 million brain neurons per minute before treatment restores oxygenated blood flow. A study quantifying the “time is brain” stroke mantra found that hourly neuron loss is equivalent to more than three years of normal aging.

“The drive for simplicity in stroke is very, very strong,” Gilvarry said in a Medical Design & Ou…

New results detail J&J Embotrap design’s first-pass performance in stroke patients

A blood clot captured by the Embotrap stent retriever [Photo courtesy of Johnson & Johnson MedTech]

Johnson & Johnson (NYSE:JNJ) has released results for its Embotrap stent retrievers showing the next-generation design’s success in removing blood clots from ischemic stroke patients.

Johnson & Johnson MedTech’s Cerenovus subsidiary tracked outcomes for 1,000 ischemic stroke patients who underwent mechanical thrombectomy procedures with Embotrap devices as a first-line therapy.

“The positive preliminary findings of this research provide real-world results that demonstrate advances are possible in mechanical thrombectomy procedures to treat ischemic stroke,” Cerenovus Worldwide President Mark Dickinson said in a news release. “It is encouraging to see these positive results and realize the impact this data can have on improved patient outcomes and changing the trajectory of stroke.”<…

How an Embotrap stent retriever thrombectomy treats ischemic strokes

Michael Gilvarry is the GM of Cerenovus in Galway, Ireland. [Photo courtesy of Johnson & Johnson MedTech]Gilvarry is the GM of Cerenovus in Galway, Ireland. [Photo courtesy of Johnson & Johnson Medtech]

To catch a clot, you must first understand a clot, and Michael Gilvarry has spent years doing just that.

Gilvarry is the GM of Cerenovus in Galway, Ireland. He founded the Johnson & Johnson Medtech unit’s stroke science research arm and leads the acute ischemic stroke R&D portfolio.

That research led to the development and design of the Embotrap stent retriever device for thrombectomies, which helps stroke patients by removing the clots blocking the flow of blood to their brains.

“How the device design is informed by stroke science is something that we feel is really unique about the device,” he said in an interview. “All of that work we’ve done has le…

Johnson & Johnson’s Cerenovus launches new clot removal devices to treat stroke

Johnson & Johnson’s Cerenovus recently announced it has launched its new stroke solutions platform that includes three devices for clot removal procedures.

The three devices are designed to aid physicians in performing mechanical thrombectomy procedures. The devices include the Cerebase DA Guide Sheath, Cerenovus Large Bore Catheter and Embotrap III Revascularization Device.

Get the full story on our sister site, Medical Tubing + Extrusion.